Skip to main content
Equibles

Candriam S.C.A.

Position in NBP — NovaBridge Biosciences

CIK 1537014 STRASSEN, N4
Back to NBP Full portfolio

Position in NBP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,208,497
-$577,607 QoQ
Shares Held
1,132,563
0.0% QoQ
Ownership
0.979%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 49 holders
Holding Since
Jun 2020
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. NBP ranks #71 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 195,674 $122,010,565
2 RVMD
Revolution Medicines, Inc.
 556,392 $104,201,093
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 199,505 $99,100,118
4 ALNY
Alnylam Pharmaceuticals, Inc.
 314,512 $94,677,547
5 ONC
BeOne Medicines Ltd.
 289,735 $82,565,782
6 COGT
Cogent Biosciences, Inc.
 2,088,369 $80,819,880
7 ARGX
Argenx SE
 80,120 $74,332,932
8 ROIV
Roivant Sciences Ltd.
 1,990,510 $70,444,148

All Filings in NBP

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,208,497 1,132,563
2026-03-31 $2,786,104 1,132,563
2025-12-31 $4,507,600 1,132,563
2025-09-30 $4,281,088 1,132,563
2025-06-30 $2,740,802 1,132,563
2020-06-30 $976,436 32,624